IL-22 produced by ILC3s can contribute to development of colon cancer in a mouse model, consistent with the presence of IL-22-producing CD3− cells within human colorectal carcinoma tumors (Kirchberger et al., 2013). This evidence concerns the gene IL22 and malignant colon neoplasm.